Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline)
- 15 December 2011
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 312 (1), 11-17
- https://doi.org/10.1016/j.canlet.2011.06.032
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell deathCancer Letters, 2010
- Effect of Nitroxoline on Angiogenesis and Growth of Human Bladder CancerJNCI Journal of the National Cancer Institute, 2010
- Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells.2010
- The curious case of clioquinolNature Medicine, 2009
- Clioquinol targets zinc to lysosomes in human cancer cellsBiochemical Journal, 2008
- Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myelomaLeukemia, 2008
- Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer DiseaseArchives of Neurology, 2003
- Treatment of Alzheimer’s Disease with ClioquinolDementia and Geriatric Cognitive Disorders, 2001
- Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.Journal of Epidemiology and Community Health, 1975
- NEUROLOGICAL SYNDROME ASSOCIATED WITH CLIOQUINOLThe Lancet, 1971